Service → Milestone → Deliverable

Regulatory Affairs, milestone by milestone

Select a milestone to see what we deliver at that point in the study.

Why NoyMed

Medical judgment built to hold up under scrutiny

Anyone can staff a medical monitor. Sponsors choose the team behind the judgment calls — how consistent the review criteria are, how fast safety signals get clinical eyes, and how directly medical input carries through to the CSR and the publication record.

Grounded in the data

Medical review stays aligned with the numbers coming out of biostatistics and data management — no surprises between the listings and the review.

Safety, built in

Signal management and safety review run in step with pharmacovigilance, not bolted on after the fact.

Connected downstream

Medical input feeds straight into the CSR and publication plan — no reconciliation step.

Consistent review, every site

Medical review guidelines applied the same way across every investigator, not left to individual interpretation.

KOL relationships that outlast one meeting

Advisory boards and KOL engagement managed as an ongoing relationship, not a single transactional touchpoint.

Audit-ready throughout

Medical monitoring plans, review logs, and correspondence pass through the same quality assurance review as every other deliverable.

Beyond the standard deliverables

Additional regulatory affairs capabilities

Agency-facing regulatory support that doesn't map to a single milestone — available as standalone engagements or layered onto a full study team.

Marketing authorization

NDA support, coordinating documents for the marketing application.

What sponsors say

Feedback we hear most

Common questions

Before you reach out

What sponsors typically ask before handing over medical monitoring and scientific communication.

Ready to talk about your medical monitoring plan?

Tell us your study phase, therapeutic area, and timeline — we'll walk through how our medical affairs team plugs in.